Follow the people · Insider
Robert Andrade
Robert Andrade files insider transactions with the SEC as a chief financial officer of Fennec Pharmaceuticals (FENC). We hold 1 disclosed purchase or sale filed since 20 August 2010, 1 of them in the last 90 days.
- Files forFENC
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure31 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 February 2018 — 31 August 2026Chief Financial Officer · Fennec Pharmaceuticals (FENC)98 Form 4 lines · source: SEC Form 4
- Filed 18 August 2010 — 18 August 2010Na · Adherex Technologies (ADHXF)1 Form 4 line · source: SEC Form 4
Everything they disclosed
99 entries, newest first — one per disclosure report, one per Form 4 line- was granted 1,703 shares of Fennec PharmaceuticalsSEC Form 431 August 2026Common shares · traded 31 August 2026 · filed 31 August 2026
- ▼ sold on the open market 75,000 shares of Fennec PharmaceuticalsSEC Form 428 August 2026Common shares · traded 27 August 2026 · filed 28 August 2026
- exercised options over 21,928 shares of Fennec PharmaceuticalsSEC Form 428 August 2026Common shares · traded 28 August 2026 · filed 28 August 2026
- exercised options over 21,928 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 428 August 2026Stock Options · traded 28 August 2026 · filed 28 August 2026
- was granted 1,703 shares of Fennec PharmaceuticalsSEC Form 43 August 2026Common shares · traded 31 July 2026 · filed 3 August 2026
- was granted 1,703 shares of Fennec PharmaceuticalsSEC Form 41 July 2026Common shares · traded 30 June 2026 · filed 1 July 2026
- was granted 1,703 shares of Fennec PharmaceuticalsSEC Form 41 June 2026Common shares · traded 31 May 2026 · filed 1 June 2026
- exercised options over 1,703 shares of Fennec PharmaceuticalsSEC Form 41 May 2026Common shares · traded 30 April 2026 · filed 1 May 2026
- exercised options over 14,724 shares of Fennec PharmaceuticalsSEC Form 42 April 2026Common shares · traded 31 March 2026 · filed 2 April 2026
- exercised options over 2,213 shares of Fennec PharmaceuticalsSEC Form 42 April 2026Common shares · traded 31 March 2026 · filed 2 April 2026
- exercised options over 12,270 shares of Fennec PharmaceuticalsSEC Form 42 April 2026Common shares · traded 28 March 2026 · filed 2 April 2026
- was granted 120,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 42 April 2026Stock Options · traded 31 March 2026 · filed 2 April 2026
- exercised options over 13,072 shares of Fennec PharmaceuticalsSEC Form 426 March 2026Common shares · traded 26 March 2026 · filed 26 March 2026
- exercised options over 13,072 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 426 March 2026Stock Options · traded 26 March 2026 · filed 26 March 2026
- exercised options over 13,072 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 426 March 2026Stock Options · traded 26 March 2026 · filed 26 March 2026
- exercised options over 13,072 shares of Fennec PharmaceuticalsSEC Form 426 March 2026Common shares · traded 26 March 2026 · filed 26 March 2026
- was granted 1,191 shares of Fennec PharmaceuticalsSEC Form 43 March 2026Common shares · traded 28 February 2026 · filed 3 March 2026
- was granted 1,191 shares of Fennec PharmaceuticalsSEC Form 43 March 2026Common shares · traded 28 February 2026 · filed 3 March 2026
- exercised options over 2,450 shares of Fennec PharmaceuticalsSEC Form 419 February 2026Common shares · traded 18 February 2026 · filed 19 February 2026
- exercised options over 27,285 shares of Fennec PharmaceuticalsSEC Form 419 February 2026Common shares · traded 18 February 2026 · filed 19 February 2026
- exercised options over 2,450 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 419 February 2026Stock Options · traded 18 February 2026 · filed 19 February 2026
- exercised options over 2,450 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 419 February 2026Stock Options · traded 18 February 2026 · filed 19 February 2026
- exercised options over 2,450 shares of Fennec PharmaceuticalsSEC Form 419 February 2026Common shares · traded 18 February 2026 · filed 19 February 2026
- exercised options over 27,285 shares of Fennec PharmaceuticalsSEC Form 419 February 2026Common shares · traded 18 February 2026 · filed 19 February 2026
- was granted 1,558 shares of Fennec PharmaceuticalsSEC Form 42 February 2026Common shares · traded 31 January 2026 · filed 2 February 2026
- was granted 1,558 shares of Fennec PharmaceuticalsSEC Form 42 February 2026Common shares · traded 31 January 2026 · filed 2 February 2026
- exercised options over 10,000 shares of Fennec PharmaceuticalsSEC Form 423 January 2026Common shares · traded 23 January 2026 · filed 23 January 2026
- exercised options over 10,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 423 January 2026Stock Options · traded 23 January 2026 · filed 23 January 2026
- exercised options over 10,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 423 January 2026Stock Options · traded 23 January 2026 · filed 23 January 2026
- exercised options over 10,000 shares of Fennec PharmaceuticalsSEC Form 423 January 2026Common shares · traded 23 January 2026 · filed 23 January 2026
- exercised options over 10,000 shares of Fennec PharmaceuticalsSEC Form 415 January 2026Common shares · traded 15 January 2026 · filed 15 January 2026
- exercised options over 10,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 415 January 2026Stock Options · traded 15 January 2026 · filed 15 January 2026
- exercised options over 10,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 415 January 2026Stock Options · traded 15 January 2026 · filed 15 January 2026
- exercised options over 10,000 shares of Fennec PharmaceuticalsSEC Form 415 January 2026Common shares · traded 15 January 2026 · filed 15 January 2026
- exercised options over 14,184 shares of Fennec PharmaceuticalsSEC Form 47 January 2026Common shares · traded 7 January 2026 · filed 7 January 2026
- exercised options over 14,184 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 47 January 2026Stock Options · traded 7 January 2026 · filed 7 January 2026
- exercised options over 14,184 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 47 January 2026Stock Options · traded 7 January 2026 · filed 7 January 2026
- exercised options over 14,184 shares of Fennec PharmaceuticalsSEC Form 47 January 2026Common shares · traded 7 January 2026 · filed 7 January 2026
- was granted 1,382 shares of Fennec PharmaceuticalsSEC Form 45 January 2026Common shares · traded 31 December 2025 · filed 5 January 2026
- was granted 1,382 shares of Fennec PharmaceuticalsSEC Form 45 January 2026Common shares · traded 31 December 2025 · filed 5 January 2026
- was granted 2,430 shares of Fennec PharmaceuticalsSEC Form 42 December 2025Common shares · traded 1 December 2025 · filed 2 December 2025
- was granted 2,430 shares of Fennec PharmaceuticalsSEC Form 43 November 2025Common shares · traded 31 October 2025 · filed 3 November 2025
- was granted 2,430 shares of Fennec PharmaceuticalsSEC Form 41 October 2025Common shares · traded 30 September 2025 · filed 1 October 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 42 September 2025Common shares · traded 31 August 2025 · filed 2 September 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 41 August 2025Common shares · traded 31 July 2025 · filed 1 August 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 41 July 2025Common shares · traded 30 June 2025 · filed 1 July 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 42 June 2025Common shares · traded 31 May 2025 · filed 2 June 2025
- exercised options over 8,220 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 423 May 2025Stock Options · traded 22 May 2025 · filed 23 May 2025
- exercised options over 8,220 shares of Fennec PharmaceuticalsSEC Form 423 May 2025Common shares · traded 22 May 2025 · filed 23 May 2025
- was granted 16,667 shares of Fennec PharmaceuticalsSEC Form 419 May 2025Common shares · traded 16 May 2025 · filed 19 May 2025
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 41 May 2025Common shares · traded 30 April 2025 · filed 1 May 2025
- was granted 75,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 April 2025Restricted Share Unit · traded 28 March 2025 · filed 3 April 2025
- was granted 50,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 April 2025Stock Options · traded 28 March 2025 · filed 3 April 2025
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 41 April 2025Common shares · traded 31 March 2025 · filed 1 April 2025
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 428 February 2025Common shares · traded 28 February 2025 · filed 28 February 2025
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 43 February 2025Common shares · traded 31 January 2025 · filed 3 February 2025
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 43 January 2025Common shares · traded 31 December 2024 · filed 3 January 2025
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 42 December 2024Common shares · traded 2 December 2024 · filed 2 December 2024
- exercised options over 15,816 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 418 November 2024Stock Options · traded 18 November 2024 · filed 18 November 2024
- exercised options over 15,816 shares of Fennec PharmaceuticalsSEC Form 418 November 2024Common shares · traded 18 November 2024 · filed 18 November 2024
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 44 November 2024Common shares · traded 31 October 2024 · filed 4 November 2024
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 41 October 2024Common shares · traded 30 September 2024 · filed 1 October 2024
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 44 September 2024Common shares · traded 31 August 2024 · filed 4 September 2024
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 41 August 2024Common shares · traded 31 July 2024 · filed 1 August 2024
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 42 July 2024Common shares · traded 1 July 2024 · filed 2 July 2024
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 43 June 2024Common shares · traded 31 May 2024 · filed 3 June 2024
- was granted 100,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 421 May 2024Stock Option (right to buy) · traded 16 May 2024 · filed 21 May 2024
- was granted 50,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 421 May 2024Restricted Share Unit (right to receive value of a share) · traded 16 May 2024 · filed 21 May 2024
- was granted 1,042 shares of Fennec PharmaceuticalsSEC Form 42 May 2024Common shares · traded 30 April 2024 · filed 2 May 2024
- ▲ bought on the open market 12,500 shares of Fennec PharmaceuticalsSEC Form 43 April 2024Common shares · traded 1 April 2024 · filed 3 April 2024
- ▼ sold on the open market 13,975 shares of Fennec PharmaceuticalsSEC Form 427 March 2024Common shares · traded 26 March 2024 · filed 27 March 2024
- ▼ sold on the open market 13,975 shares of Fennec PharmaceuticalsSEC Form 425 March 2024Common shares · traded 25 March 2024 · filed 25 March 2024
- ▼ sold on the open market 15,000 shares of Fennec PharmaceuticalsSEC Form 45 January 2024Common shares · traded 4 January 2024 · filed 5 January 2024
- ▼ sold on the open market 15,000 shares of Fennec PharmaceuticalsSEC Form 45 January 2024Common shares · traded 5 January 2024 · filed 5 January 2024
- exercised options over 25,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 430 June 2023Common Shares · traded 30 June 2023 · filed 30 June 2023
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 430 June 2023Common shares · traded 28 June 2023 · filed 30 June 2023
- ▼ sold on the open market 7,500 shares of Fennec PharmaceuticalsSEC Form 430 June 2023Common shares · traded 29 June 2023 · filed 30 June 2023
- ▼ sold on the open market 7,500 shares of Fennec PharmaceuticalsSEC Form 430 June 2023Common shares · traded 30 June 2023 · filed 30 June 2023
- exercised options over 25,000 shares of Fennec PharmaceuticalsSEC Form 430 June 2023Common shares · traded 30 June 2023 · filed 30 June 2023
- was granted 75,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 April 2023Stock Option (right to buy) · traded 31 March 2023 · filed 3 April 2023
- was granted 37,500 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 April 2023Restricted Share Unit (right to receive value of a share) · traded 31 March 2023 · filed 3 April 2023
- ▼ sold on the open market 11,000 shares of Fennec PharmaceuticalsSEC Form 430 December 2022Common shares · traded 28 December 2022 · filed 30 December 2022
- ▼ sold on the open market 5,500 shares of Fennec PharmaceuticalsSEC Form 430 December 2022Common shares · traded 29 December 2022 · filed 30 December 2022
- ▼ sold on the open market 5,500 shares of Fennec PharmaceuticalsSEC Form 430 December 2022Common shares · traded 30 December 2022 · filed 30 December 2022
- was granted 37,500 shares of Fennec PharmaceuticalsSEC Form 422 September 2022Common shares · traded 21 September 2022 · filed 22 September 2022
- returned to the issuer 19,052 shares of Fennec PharmaceuticalsSEC Form 422 September 2022Common shares · traded 21 September 2022 · filed 22 September 2022
- was granted 75,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 420 December 2021Stock Option (right to buy) · traded 20 December 2021 · filed 20 December 2021
- was granted 37,500 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 420 December 2021Restricted Share Unit (right to receive value of a share) · traded 20 December 2021 · filed 20 December 2021
- was granted 100,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 June 2021Stock Option (right to buy) · traded 2 June 2021 · filed 3 June 2021
- exercised options over 323,961 shares of Fennec PharmaceuticalsSEC Form 417 August 2020Common shares · traded 13 August 2020 · filed 17 August 2020
- had shares withheld for tax on 97,136 shares of Fennec PharmaceuticalsSEC Form 417 August 2020Common shares · traded 13 August 2020 · filed 17 August 2020
- had shares withheld for tax on 38,828 shares of Fennec PharmaceuticalsSEC Form 417 August 2020Common shares · traded 13 August 2020 · filed 17 August 2020
- had shares withheld for tax on 38,900 shares of Fennec PharmaceuticalsSEC Form 417 August 2020Common shares · traded 14 August 2020 · filed 17 August 2020
- had shares withheld for tax on 12,874 shares of Fennec PharmaceuticalsSEC Form 417 August 2020Common shares · traded 17 August 2020 · filed 17 August 2020
- was granted 125,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 415 May 2020Stock Option (right to buy) · traded 15 May 2020 · filed 15 May 2020
- was granted 80,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 48 April 2019Stock Option (right to buy) · traded 4 April 2019 · filed 8 April 2019
- exercised options over 17,050 shares of Fennec PharmaceuticalsSEC Form 417 August 2018Common Stock · traded 15 August 2018 · filed 17 August 2018
- was granted 50,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 48 February 2018Stock Option (right to buy) · traded 6 February 2018 · filed 8 February 2018
- was granted an unstated number of shares of Adherex Technologies (a derivative holding)SEC Form 420 August 2010Common Stock Options (right to buy) · traded 18 August 2010 · filed 20 August 2010
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.